Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation [ChIP-Seq]

ABSTRACT: Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation [ChIP-Seq]

PROVIDER: PRJNA917631 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22957142_1.fastq.gz	Fastqsanger.gz
	SRR22957142_2.fastq.gz	Fastqsanger.gz
	SRR22957143_1.fastq.gz	Fastqsanger.gz
	SRR22957143_2.fastq.gz	Fastqsanger.gz
	SRR22957144_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation [D7-EZH2-RNAseq]

Project description:To demonstrate that EZH2 regulates human erythropoiesis in a stage-specific, dual-function manner by catalyzing histone and non-histone methylation, we performed RNA-seq and ChIP-seq.

2024-01-01 | GSE222114 | GEO

Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation [D15-EZH2-RNAseq]

Project description:To demonstrated that EZH2 regulates human erythropoiesis in a stage-specific, dual-function manner by catalyzing histone and non-histone methylation,We performed RNA-seq and ChIP-seq.

2024-01-01 | GSE221932 | GEO

Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation [ChIP-Seq]

2024-01-01 | GSE222079 | GEO

Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation

Project description:Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation

| PRJNA918306 | ENA

Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation [D15-EZH2-RNAseq]

Project description:Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation [D15-EZH2-RNAseq]

| PRJNA916879 | ENA

Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation [D7-EZH2-RNAseq]

Project description:Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation [D7-EZH2-RNAseq]

| PRJNA918309 | ENA

Nuclear IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming

Project description:Nuclear IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming

| PRJNA921873 | ENA

Nuclear IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming

Project description:Nuclear IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming

| PRJNA919172 | ENA

Histone PTM profiling analysis of EZH2 mutants in isogenic cells

Project description:The Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2) is an essential epigenetic modifier able to methylate lysine 27 on histone H3 (H3K27) to induce chromatin compaction, protein complex recruitment and ultimately transcriptional repression. Hematologic malignancies, including Diffuse Large B cell lymphoma (DLBCL) and Acute myeloid leukemia (AML) have shown a high EZH2-mutation frequency (>20%) associated with poor clinical outcomes. Particularly, two distinct oncogenic mutations, so-called gain-of-function (Y641F and A677G) and loss-of-function (H689A and F667I) are found in the catalytic domain of EZH2. In this study, a comprehensive multi-omics approach was employed to characterize downstream effects of H3K27me3 deposition driven by EZH2 mutations. Human embryonic kidney cells (HEK293T) were transfected to generate three stable EZH2 mutants: EZH2(Y641F), EZH2(A677G), and EZH2(H689A/F667I), which were validated via immunoblotting and DIA-MS-based histone profiling assay. The histone profiling assay demonstrated a significant increase of approximately two-fold in H3.1/H3.3K27me3 for Y641F EZH2 mutant. There was a modest increase in the combinatorial PTMs H3.1/H3.3K27me3K36me1 and a significant depletion in H3.1 and H3.3 K27me2. The most depleted peptide was H3.3K27me2K36me2. For the A677G EZH2 mutant, the assay demonstrated an enrichment on H3.1/H3.3K27me3, combinatorial K27me3K36me1 and a slight increase in K27me1 and K18ac but only on H3.1. The most depleted peptide was H3.3K27me2K36me2. The H689A/F667I cell line has the most alterations in global histone PTMs. The most highly enriched were H3.1/H3.3K36me2, H3.1K9me3 and H3.3K36me1. The most depleted modifications were H3.1K23ac and H3.1K27me3.

2023-10-24 | PXD042953 | Pride

Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-01-01 | GSE222115 | GEO